MoS S&T launches GEMCOVAC-OM PIB Jun 26, 2023 India’s first mRNA vaccine developed using the indigenous platform technology by Gennova, with funding support from DBT &…
China approves its first mRNA vaccine from CSPC Reuters Mar 23, 2023 The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…
BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate Reuters Dec 26, 2022 The phase-I trial is expected to enroll 60 volunteers in the United States (US) with no history of malaria to evaluate the vaccine…
Japan’s Meiji Holdings says drug unit started late-stage trial for COVID vaccine Reuters Dec 15, 2022 Meiji Seika Pharma had started the late-stage trial among 780 subjects in Japan, with the test period running from November to…
Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030 Reuters Dec 13, 2022 The company provided potential revenue details from vaccines across its portfolio, including its already-approved COVID-19 vaccine…
DCGI approves India’s maiden mRNA vaccine against COVID-19 EP News Bureau Jun 29, 2022 The vaccine by Geneva Biopharma will be sold under the brand name Gemcovac-19
NIH launches clinical trial of three mRNA HIV vaccines EP News Bureau Mar 15, 2022 Phase-I study is amongst the first to examine mRNA technology for HIV
Moderna to develop mRNA-based shingles vaccine Reuters Feb 21, 2022 The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer has prompted efforts to…
WHO announces first technology recipients of mRNA vaccine hub with African and European partners EP News Bureau Feb 18, 2022 Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia to establish mRNA vaccine production
Moderna to produce millions of mRNA vaccines in Australia Reuters Dec 14, 2021 The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats…